Treatment-induced changes in tumor oxygenation predict photodynamic therapy outcome

Cancer Research

Volumn 64, Issue 20, 2004, Pages 7553-7561

  Wang, Hsing Wen ^a,b   Putt, Mary E ^a   Emanuele, Michael J ^a   Shin, Daniel B ^a   Glatstein, Eli ^a   Yodh, Arjun G ^a   Busch, Theresa M ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b B13 Anatomy and Chemistry Building ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; DIFFUSE REFLECTANCE SPECTROSCOPY; ERYTHROCYTE; FIBROSARCOMA; GENETIC VARIABILITY; MOUSE; NONHUMAN; OXYGEN AFFINITY; OXYGEN DISSOCIATION CURVE; OXYGENATION; PHOTODYNAMIC THERAPY; PREDICTION; PRIORITY JOURNAL; TUMOR GROWTH; VALIDATION PROCESS;

ANIMALS; ANTINEOPLASTIC AGENTS; CARBON DIOXIDE; DIHEMATOPORPHYRIN ETHER; ERYTHROCYTES; FIBROSARCOMA; HEMOGLOBINS; MICE; MICE, INBRED C3H; NEOPLASMS, RADIATION-INDUCED; OXYGEN; PARTIAL PRESSURE; PHOTOCHEMOTHERAPY; PREDICTIVE VALUE OF TESTS; RADIATION-SENSITIZING AGENTS; TREATMENT OUTCOME;

EID: 5644273864     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: 10.1158/0008-5472.CAN-03-3632     Document Type: Article

References (59)

1. Dougherty TJ, Gomer CJ, Henderson BW, et al. Photodynamic therapy. J Natl Cancer Inst 1998;90:889-905.
2. Tromberg BJ, Orenstein A, Kimel S, et al. In vivo tumor oxygen tension measurements for the evaluation of the efficiency of photodynamic therapy. Photochem Photobiol 1990;52:375-85.
3. Foster TH, Murant RS, Bryant RG, et al. Oxygen consumption and diffusion effects in photodynamic therapy. Radiat Res 1991;126:296-303.
4. Sitnik TM, Hampton JA, Henderson BW. Reduction of tumour oxygenation during and after photodynamic therapy in vivo: effects of fluence rate. Br J Cancer 1998; 77:1386-94.
5. Zilberstein J, Bromberg A, Frantz A, et al. Light-dependent oxygen consumption in bacteriochlorophyll-serine-treated melanoma tumors: on-line determination using a tissue-inserted oxygen microsensor. Photochem Photobiol 1997;65:1012-9.
6. Pogue BW, Braun RD, Lanzen JL, Erickson C, Dewhirst MW. Analysis of the heterogeneity of pO2 dynamics during photodynamic therapy with verteporfin. Photochem Photobiol 2001;74:700-6.
7. Pogue BW, O'Hara JA, Goodwin IA, et al. Tumor pO2 changes during photodynamic therapy depend upon photosensitizer type and time after injection. Comparative Biochemistry and Physiology Part A 2002;132:177-84.
8. Henderson BW, Busch TM, Vaughan LA, et al. Photofrin photodynamic therapy can significantly deplete or preserve oxygenation in human basal cell carcinomas during treatment, depending on fluence rate. Cancer Res 2000;60:525-9.
9. Sitnik TM, Henderson BW. The effect of fluence rate on tumor and normal tissue responses to photodynamic therapy. Photochem Photobiol 1998;67:462-6.
10. van Geel IP, Oppelaar H, Marijnissen JP, Stewart FA. Influence of fractionation and fluence rate in photodynamic therapy with Photofrin or mTHPC. Radiat Res 1996; 145:602-9.
11. Gibson SL, Foster TH, Feins RH, et al. Effects of photodynamic therapy on xenografts of human mesothelioma and rat mammary carcinoma in nude mice. Br J Cancer 1994;69:473-81.
12. Curnow A, Haller JC, Bown SG. Oxygen monitoring during 5-aminolaevulinic acid induced photodynamic therapy in normal rat colon. Comparison of continuous and fractionated light regimes. J Photochem Photobiol B 2000;58:149-55.
13. Pogue BW, O'Hara JA, Demidenki E, et al. Photodynamic therapy with verteporfin in the radiation-induced fibrosarcoma-1 tumor causes enhanced radiation sensitivity. Cancer Res 2003;63:1025-33.
14. Busch TM, Wileyto EP, Emanuele MJ, et al. Photodynamic therapy creates fluence rate-dependent gradients in the intratumoral spatial distribution of oxygen. Cancer Res 2002;62:7273-9.
15. Busch TM, Hahn SM, Evans SM, Koch CJ. Depletion of tumor oxygenation during photodynamic therapy: detection by the hypoxia marker EF3 [2-(2-Nitroimidazol-1[H]-yl)-N-(3,3,3-trifluoropropyl)acetamide]. Cancer Res 2000;60:2636-42.
16. van Geel IP, Oppelaar H, Rijken PF, et al. Vascular perfusion and hypoxic areas in RIF-1 tumours after photodynamic therapy. Br J Cancer 1996;73:288-93.
17. Moore RB, Chapman JD, Mercer JR, et al. Measurement of PDT-induced hypoxia in dunning prostate tumors by iodine-123-iodoazomycin arabinoside. J Nucl Med 1993; 34:405-11.
18. Schouwink H, Oppelaar H, Ruevekamp M, et al. Oxygen depletion during and after mTHPC-mediated photodynamic therapy in RIF1 and H-MESO1 tumors. Radiat Res 2003;159:190-8.
19. Chapman JD, McPhee MS, Walz N, et al. Nuclear magnetic resonance spectroscopy and sensitizer-adduct measurements of photodynamic therapy-induced ischemia in solid tumors. J Natl Cancer Inst 1991;83:1650-9.
20. McIlroy BW, Curnow A, Buonaccorsi G, et al. Spatial measurement of oxygen levels during photodynamic therapy using time-resolved optical spectroscopy. J Photochem Photobiol B 1998;43:47-55.
21. Pham TH, Hornung R, Berns MW, Tadir Y, Tromberg BJ. Monitoring tumor response during photodynamic therapy using near-infrared photon-migration spectroscopy. Photochem Photobiol 2001;73:669-77.
22. Solonenko M, Cheung R, Busch TM, et al. In vivo reflectance measurement of optical properties, blood oxygenation and motexafin lutetium uptake in canine large bowels, kidneys, and prostates. Phys Med Biol 2002;47:857-73.
23. Wang H-W, Zhu TC, Putt ME, et al. Broadband reflectance measurements of light penetration, blood oxygenation, hemoglobin concentration, and drug concentration in human intraperitoneal tissues before and after photodynamic therapy. J Biomedical Optics. In press 2004.
24. Bevilacqua F, Berger AJ, Cerussi D, Jakubowski D, Tromberg BJ. Broadband absorption spectroscopy in turbid media by combined frequency-domain and steady-state methods. Appl Opt 2000;39:6498-507.
25. Mourant JR, Fuselier T, Boyer J, Johnson TM, Bigio IJ. Predictions and measurements of scattering and absorption over broad wavelength ranges in tissue phantoms. Appl Opt 1997;36:949-57.
26. Zijlstra WG, Buursma A, Meeuwsen-van der Roest WP. Absorption spectra of human fetal and adult oxyhemoglobin, de-oxyhemoglobin, carboxyhemoglobin, and methemoglobin. Clin Chem 1991;37:1633-8.
27. Wray S, Cope M, Delpy DT, Wyatt JS, Reynolds EO. Characterization of the near infrared absorption spectra of cytochrome aa3 and haemoglobin for the non-invasive monitoring of cerebral oxygenation. Biochem Biophys Acta 1988;933:184-92.
28. Haskell RC, Svaasand LO, Tsay T-T, et al. Boundary conditions for the diffusion equation in radiative transfer. J Opt Soc Am A 1994;11:2727-41.
29. Kienle A, Patterson MS. Improved solutions of the steady-state and the time-resolved diffusion equations for refletance from a semi-infinite turbid medium. J Opt Soc Am A 1997;14:246-54.
30. Hull EL, Nichols MG, Foster TH. Localization of luminescent inhomogeneities in turbid media with spatially resolved measurements of CW diffuse luminescence emittance. Appl Opt 1998;37:2755-65.
31. Hull EL, Nichols MG, Foster TH. Quantitative broadband near-infrared spectroscopy of tissue-simulating phantoms containing erythrocytes. Phys Med Biol 1998;43: 3381-404.
32. Choe R, Durduran T, Yu G, et al. Transabdominal near infrared oximetry of hypoxic stress in fetal sheep brain in utero. Proc Natl Acad Sci USA 2003;100:12950-4.
33. Culver JP, Durduran T, Furaya D, et al. Diffuse optical tomography of cerebral blood flow, oxygenation and metabolism in rat during focal ischemia. J Cereb Blood Flow Metab 2003;23:911-24.
34. Durduran T, Choe R, Culver JP, et al. Bulk optical properties of healthy female breast tissue. Phys Med Biol 2002;47:2847-61.
35. Corlu A, Durduran T, Choe R, et al. Uniqueness and wavelength optimization in continuous-wave multispectral diffuse optical tomography. Optics Letters 2003;28: 2339-41.
36. MacDonald IJ, Dougherty TJ. Basic principles of photodynamic therapy. J Porphyrins Phthalocyanines 2001;5:105-29.
37. Koch CJ. Oxygen sensor design: analysis and correction of problems associated with zero current, stability and structure. Adv Exp Med Biol 2003;510:151-6.
38. Hosmer DW, Lemeshow S. Applied survival analysis: regression modeling of time to event data. New York: John Wiley and Sons Inc., 1999.
39. Ihaka R, Gentleman R. R: a language for data analysis and graphics. J Computational and Graphical Statistics 1996;5:299-314.
40. Efron B, Tibshirani RJ. An introduction to the bootstrap. New York: Chapman and Hall; 1993.
41. Hull EL, Conover DL, Foster TH. Carbogen-induced changes in rat mammary tumor oxygenation reported by near infrared spectroscopy. Br J Cancer 1999;79:1709-16.
42. Cheung C, Culver JP, Takahashi K, Greenberg JH, Yodh AG. In vivo cerebrovascular measurement combining diffuse near-infrared absorption and correlation spectroscopies. Phys Med Biol 2001;46:2053-65.
43. Mitra S, Foster TH. Carbogen breathing significantly enhances the penetration of red light in murine tumours in vivo. Phys Med Biol 2004;49:1891-904.
44. Conover DL, Fenton BM, Foster TH, Hull EL. An evaluation of near infrared spectroscopy and cryospectrophotometry estimates of haemoglobin oxygen saturation in a rodent mammary tumour model. Phys Med Biol 2000;45:2685-700.
45. Durduran T, Yu G, Zhou C, et al. Diffuse optical measurements of blood flow, blood oxygenation and metabolism in human brain during sensorimotor cortex activation. Optics Letters 2004;29:1766-8.
46. Menon C, Polin GM, Prabakaran I, et al. An integrated approach to measuring tumor oxygen status using human melanoma xenografts as a model. Cancer Res 2003;63: 7232-40.
47. Gray LH, Steadman JM. Determination of the oxyhaemoglobin dissociation curves for mouse and rat blood. J Physiol 1964;175:161-71.
48. Coutier S, Bezdetnaya LN, Foster TH, Parache RM, Guillemin F. Effect of irradiation fluence rate on the efficacy of photodynamic therapy and tumor oxygenation in meta-tetra (hydroxyphenyl) chlorin (mTHPC)-sensitized HT29 xenografts in nude mice. Radiat Res 2002;158:339-45.
49. Sokolov VE. Mammal skin. Berkeley Los Angeles London: University of California Press; 1982.
50. Henderson BW, Fingar VH. Relationship of tumor hypoxia and response to photodynamic treatment in an experimental mouse tumor. Cancer Res 1987;47:3110-4.
51. Fingar VH, Wieman TJ, Park YJ, Henderson BW. Implications of a pre-existing tumor hypoxic fraction on photodynamic therapy. J Surg Res 1992;53:524-8.
52. Rofstad EK, Fenton BM, Sutherland RM. Intracapillary HbO2 saturations in murine tumours and human tumour xenografts measured by cryospectrophotometry: Relationship to tumour volume, tumour pH and fraction of radiobiologically hypoxic cells. Br J Cancer 1988;57:494-502.
53. Srinivasan S, Pogue BW, Jiang S, et al. Interpreting hemoglobin and water concentration, oxygen saturation, and scattering measured in vivo by near-infrared breast tomography. Proc Natl Acad Sci USA 2003;100:12349-54.
54. Cheung R, Solonenko M, Busch TM, et al. Correlation of in vivo photosensitizer fluorescence and photodynamic-therapy-induced depth of necrosis in a murine tumor model. J Biomedical Optics 2003;8:248-52.
55. Niedre MJ, Secord AJ, Patterson MS, Wilson BC. In vitro tests of the validity of singlet oxygen luminescence measurements as a dose metric in photodynamic therapy. Cancer Res 2003;63:7986-94.
56. Pogue BW, Pitts JD, Mycek M-A, et al. In vivo NADH fluorescence monitoring as an assay for cellular damage in photodynamic therapy. Photochem Photobiol 2001; 74:817-24.
57. 31P magnetic resonance spectroscopy as a predictor of efficacy in photodynamic therapy using differently charged zinc phthalocyanines. Br J Cancer 1999;81:616-21.
58. Nishiwaki M, Fujise Y, Yoshida TO, Matsuzawa E, Nishiwaki Y. Evaluation of the effects of photodynamic therapy with phosphorus 31 magnetic resonance spectroscopy. Br J Cancer 1999;80:133-41.
59. Gross S, Gilead A, Scherz A, Neeman M, Salomon Y. Monitoring photodynamic therapy of solid tumors online by BOLD-contrast MRI. Nat Med 2003;9:1327-31.